Ravert v. Monroe County

CourtDistrict Court, M.D. Pennsylvania
DecidedSeptember 30, 2022
Docket4:20-cv-00889
StatusUnknown

This text of Ravert v. Monroe County (Ravert v. Monroe County) is published on Counsel Stack Legal Research, covering District Court, M.D. Pennsylvania primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Ravert v. Monroe County, (M.D. Pa. 2022).

Opinion

UNITED STATES DISTRICT COURT MIDDLE DISTRICT OF PENNSYLVANIA SHAWN RAVERT, ) CIVIL ACTION NO. 4:20-CV-889 Plaintiff ) ) v. ) ) (ARBUCKLE, M.J.) MONROE COUNTY, et al., ) Defendants ) MEMORANDUM OPINION Defendants’ Motion for Summary Judgment (Doc. 43) I. INTRODUCTION In 2016 Shawn Ravert (“Plaintiff”) was an inmate in the Monroe County Correctional Facility (“MCCF”). He alleges that the medical staff at this facility failed to make a timely diagnosis of what turned out to be a malignant melanoma. Plaintiff sued the County, the private corporation contracted by the County to provide medical care at the County facility, three members of the medical staff (employed by the private corporation), and ten John Doe’s alleging Eighth & Fourteenth Amendment deliberate indifference, a Monell claim, and assorted medical negligence claims. All Defendants seek summary judgment on all claims in a single motion (Doc. 43). The matter is before me on Consent. The Motion for Summary Judgment is briefed and ready for decision. The sequence of events that

ultimately lead to Mr. Ravert’s cancer surgery are generally agreed upon. How to interpret those events is however, disputed. II. FACTUAL BACKGROUND A. GENERALLY Ravert alleges that in providing him medical care at the Monroe County

Correctional Facility, medical staff failed to recognize the onset of a malignant melanoma on his right shin in December 2016. He claims deliberate indifference to serious medical needs and medical negligence.

To show deliberate indifference he asserts, among other things, the medical defendants failed to have proper stitching equipment to remove the lesion when he first saw a doctor in December 2016, and then intentionally discarded the

suspicious lesion a few days later (a lesion he removed himself) rather than preserve or send it for pathologic analysis. The Defendants concede the nurse didn’t save or send the tissue because they did not have the proper supplies to preserve the sample for the lab. Ravert alleges the deliberate indifference

continued when they failed to re-check or monitor what they recklessly determined without any testing was a benign skin tag; and when they failed to refer Mr. Ravert to the appropriate specialist.

As a result of their deliberate indifference to this serious medical need, Mr. Ravert alleges his cancer was not diagnosed until eighteen months later in June 2018. In December 2016, Mr. Ravert had, he alleges, a totally curable pre- cancerous or Stage I disease at worst. However, the 18-month delay in diagnosis allowed it to progress to pathologic Stage IIIC, which, according to plaintiff, carries a melanoma-specific prognosis of 5-year 69% survival, 10-year 60%

survival. The Court is now called upon by way of summary judgment to decide if there is sufficient evidence to allow any or all claims to go to trial. The defense

asserts all Constitutional claims against all defendants should be dismissed. Ravert insists that all claims should go to trial. To decide these motions the Court will review the allegations in the complaint, the statements of undisputed material facts from each side and the legal arguments set forth in the competing briefs.

B. THE COMPLAINT A general understanding of this case is detailed in the Complaint (Doc. 1) which is summarized here. Beginning in October 2016, Plaintiff was incarcerated at MCCF. (Doc. 1, ¶19). On December 14, 2016, a lesion or “skin tag” on

Plaintiff’s right shin started bleeding while Plaintiff was playing basketball. (Doc. 1 ¶ 20). Plaintiff sought medical care at MCCF’s medical department. Id. Medical staff provided wound care and discharged Plaintiff without further examination. Id.

On December 26, 2016, Plaintiff attempted to remove the lesion by himself, using a piece of string. (Doc. 1 ¶ 21). Following this attempt, Plaintiff again sought medical care at MCCF’s medical department. Id. On December 27, 2016, Defendant Kenneth Wloczewski examined the lesion on Plaintiff’s leg. (Doc. 1, ¶ 22). During that examination, Defendant

Wloczewski noted that the lesion had been present for one year and that removal was scheduled for the following week. Id. On December 28, 2016, Plaintiff was examined at the MCCF Medical

Department for follow-up. (Doc. 1 ¶ 23). During the examination, the lesion was “still intact” but appeared to be detaching from Plaintiff’s leg due to Plaintiff’s attempt to remove it. Id. An unidentified nurse provided wound care. Id. On December 29, 2016, Plaintiff was examined by another unidentified

nurse at the MCCF Medical Department. (Doc. 1, ¶ 24). During the examination, the lesion was “still intact” but appeared to be detaching from Plaintiff’s leg due to Plaintiff’s attempt to remove it. Id. A nurse provided wound care. Id.

Later the same evening, however, the lesion fell off. (Doc. 1 ¶ 25). When it did, Plaintiff was examined by Defendant Grace Ramos, a nurse at the MCCF Medical Department. Id. Defendant Ramos provided wound care to stop the bleeding. Id. She also conferred with an unidentified “on-call provider” by

telephone to ask about preservation of the lesion that “fell off.” Id. There was no preservative in the office. Id. Based on this information Defendant Ramos was instructed to discard the lesion. Id. On January 3, 2017, Defendant Wloczewski examined Plaintiff. (Doc. 1, ¶ 26). Defendant Wloczewski noted that the “skin tag” had fallen off and was gone.

(Doc. 1, ¶ 26). Eleven months later, on December 12, 2017, Plaintiff’s right leg began to bleed in the same area while playing basketball. (Doc. 1, ¶ 27). He was examined

by unidentified staff members at the MCCF Medical Department. Id. During the examination, medical staff observed the presence of a polypoid lesion, provided wound care, and discharged Plaintiff without further examination, restriction, or referral to the on-call provider or another specialist. (Doc. 1, ¶ 27).

Six months later, on June 7, 2018, Plaintiff was examined by Defendant Paulina Foley (a physician’s assistant at MCCF) with complaints of redness and irritation of the skin on his right leg. (Doc. 1, ¶ 28). Defendant Foley noted a rash

in the shape of a bullseye with a quarter-sized fleshly nodule in the center, and performed a punch biopsy to remove a portion of the nodule for analysis. Id. On June 15, 2018, eighteen months after the skin tag was brought to the attention of the MCCF staff and seventeen months after the skin tag fell off,

Plaintiff was diagnosed with invasive malignant melanoma. (Doc. 1, ¶ 29). On June 18, 2018, Dr. Akan Westheim confirmed the diagnosis of malignant melanoma. (Doc. 1, ¶ 30). On September 6, 2018, Oncologist Mathew Miceli examined Plaintiff. (Doc. 1, ¶ 31). Dr. Miceli referred Plaintiff to surgical oncology for a wide resection of

the melanoma, with a sentinel lymph node biopsy. Id. On September 14, 2018, Dermatologist Quy Pham examined Plaintiff. (Doc. 1, ¶ 32). Dr. Pham noted that the melanoma had grown and occasionally bled. Id.

Plaintiff was referred to skin oncology for treatment and staging. Id. On September 27, 2018, Oncologist Colette R. Pameijer took a second biopsy of the lesion. (Doc. 1 ¶ 33). Dr. Pameijer recommended Plaintiff undergo a wide local excision and sentinel node biopsy. Id. Dr. Pameijer anticipated that

Plaintiff would need to undergo a skin graft a few weeks after the excision and estimated that there was a 30% chance the cancer had spread to Plaintiff’s sentinel lymph node. Id.

On October 15, 2018, Plaintiff had a third biopsy at Hershey Medical Center. (Doc. 1 ¶ 34). The biopsy showed T3b melanoma. Id. On November 21, 2018, a positron emission tomography (“PET”) scan showed intense fluorodeoxyglucose (“FDG”) activity (indicative of possible cancer) in Plaintiff’s

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Estelle v. Gamble
429 U.S. 97 (Supreme Court, 1976)
Monell v. New York City Dept. of Social Servs.
436 U.S. 658 (Supreme Court, 1978)
Smith v. Wade
461 U.S. 30 (Supreme Court, 1983)
Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Scott v. Harris
550 U.S. 372 (Supreme Court, 2007)
Jones v. Muskegon County
625 F.3d 935 (Sixth Circuit, 2010)
Lonnie A. Massey v. Terrell Don Hutto
545 F.2d 45 (Eighth Circuit, 1976)
Farmer v. Brennan
511 U.S. 825 (Supreme Court, 1994)
Goudy-Bachman v. United States Department of Health & Human Services
811 F. Supp. 2d 1086 (M.D. Pennsylvania, 2011)
Thomas v. Dragovich
142 F. App'x 33 (Third Circuit, 2005)
Keller v. County of Bucks
209 F. App'x 201 (Third Circuit, 2006)
Marc Stephens v. City of Englewood
689 F. App'x 710 (Third Circuit, 2017)
Natale v. Camden County Correctional Facility
318 F.3d 575 (Third Circuit, 2003)
Tenon v. Dreibelbis
190 F. Supp. 3d 412 (M.D. Pennsylvania, 2016)
Ponzini v. PrimeCare Medical, Inc.
269 F. Supp. 3d 444 (M.D. Pennsylvania, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
Ravert v. Monroe County, Counsel Stack Legal Research, https://law.counselstack.com/opinion/ravert-v-monroe-county-pamd-2022.